Welcome to our dedicated page for Sono Tek SEC filings (Ticker: SOTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sono-Tek Corporation (Nasdaq: SOTK) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Sono-Tek is incorporated in New York, and its recent filings include multiple current reports on Form 8-K and a definitive proxy statement on Schedule 14A, all of which help investors understand the company’s operations, governance, and material events.
Recent Form 8-K filings for Sono-Tek cover results of operations and financial condition, including quarterly earnings releases, as well as material orders such as multi-million dollar medical device coating system contracts. Other 8-Ks report on shareholder meeting presentations and voting outcomes, including director elections, auditor ratification, and advisory votes on executive compensation and the frequency of such votes.
The company’s definitive proxy statement (DEF 14A) outlines matters submitted to shareholders at the annual meeting, such as the election of directors and approval of auditors, and provides detail on governance structure and compensation policies. Together with periodic reports not listed here, these filings form the core regulatory record for SOTK.
On Stock Titan, Sono-Tek’s filings are updated in near real time from the SEC’s EDGAR system. AI-powered summaries help explain the key points of lengthy documents, so readers can quickly see what changed in a quarter, how large orders are disclosed, or how shareholder votes were cast. Users can review 8-Ks for earnings and major contracts, proxy materials for governance information, and other filings to build a fuller picture of Sono-Tek’s financial reporting, risk disclosures, and corporate actions.